Di Wen
Impact in
- Pharmaceutical Science top 0.2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Advancements in Transdermal Drug Delivery 7
- Immunology 23
- Immunotherapy and Immune Responses 8
- Invertebrate Immune Response Mechanisms 6
- Immune cells in cancer 6
Di Wen
74 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Pharmaceutical Science 1.0k
- Immunology 1.5k
- Biomaterials 901
- Dermatology 421
- Biomedical Engineering 2.0k
Countries citing papers authored by Di Wen
This map shows the geographic impact of Di Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Wen more than expected).
Fields of papers citing papers by Di Wen
This network shows the impact of papers produced by Di Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Wen. The network helps show where Di Wen may publish in the future.
Co-authors
The 25 scholars most cited alongside Di Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 18 | |
| 6 | 2022 | 28 | |
| 7 | 2021 | 62 | |
| 8 | 2020 | 205 | |
| 9 | 2020 | 95 | |
| 10 | 2020 | 2 | |
| 11 | 2018 | 14 | |
| 12 | 2018 | 32 | |
| 13 | 2017 | 60 | |
| 14 | 2017 | 50 | |
| 15 | 2017 | 6 | |
| 16 | 2016 | 151 | |
| 17 | 2016 | 43 | |
| 18 | 2013 | 41 | |
| 19 | 2010 | 53 | |
| 20 | Thrombin induced MO/MA differentiation into a M2 like subset with TAM characteristics in ovarian cancer. | 2009 | 1 |
About Di Wen
Di Wen is a scholar working on Pharmaceutical Science, Immunology, Horticulture, Genetics and Neurology, having authored 75 papers that have together received 5.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Neurobiology and Insect Physiology Research (10 papers), Amyotrophic Lateral Sclerosis Research (10 papers), Immunotherapy and Immune Responses (8 papers), Advancements in Transdermal Drug Delivery (7 papers), RNA Interference and Gene Delivery (7 papers), Invertebrate Immune Response Mechanisms (6 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Pharmaceutical Science (1.0k citations), Immunology (1.5k citations), Biomaterials (901 citations), Dermatology (421 citations) and Biomedical Engineering (2.0k citations). Di Wen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhen Gu, Jinqiang Wang, Quanyin Hu, Guojun Chen, Gianpietro Dotti, Xudong Zhang, Chao Wang, Qian Chen, Yanqi Ye and Zejun Wang. Their work appears in journals such as Journal of Controlled Release, Insect Biochemistry and Molecular Biology, BMC Genomics, Ecotoxicology and Environmental Safety and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.